Worth Asset Management »

Vertex Pharmaceuticals Incorporated shares owned by Worth Asset Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Worth Asset Management from 13F filings

Historical chart of Worth Asset Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Worth Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Worth Asset Management

Quarter filed Position value Share count Share price at filing
2026-09-30 $952k 1.8k 522.78
2024-09-30 $385k 828 465.08

More positions owned by Worth Asset Management

Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Ishares Core 60/40 Balanced Allocation Etf Etf (AOR)
State Street Spdr Portfolio S&p 500 Etf Etf (SPYM)
Jpmorgan Ultra-short Income Etf Etf (JPST)
Invesco Nasdaq 100 Etf Etf (QQQM)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Apple Stock (AAPL)
Capital Group Core Balanced Etf Etf (CGBL)
State Street Spdr Dow Jones Industrial Average Etf Trust Etf (DIA)
Ishares Iboxx $ High Yield Corporate Bond Etf Etf (HYG)
Ishares Treasury Floating Rate Bond Etf Etf (TFLO)
Vanguard Morningstar Value Etf Etf (VTV)
Microsoft Corp Stock (MSFT)

View all positions for Worth Asset Management

Top funds holding Vertex Pharmaceuticals Incorporated

BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Invesco
Jpmorgan Chase & Co
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Franklin Resources
Wellington Management Company
Ubs Global Asset Management Americas
Bank of America Corporation
Alliancebernstein

View all funds holding Vertex Pharmaceuticals Incorporated